AI-Powered insulin dosing shows promise for diabetes control
NCT ID NCT07291804
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether an intelligent insulin-dosing decision support system could help adults with type 2 diabetes manage their blood sugar better than standard care. 140 participants starting insulin therapy used a smart glucometer and mobile app to get algorithm-based dose recommendations. The goal was to improve blood sugar levels without increasing the risk of dangerously low blood sugar.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510630, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a heart drug tame blood sugar and weight in diabetes?
- Can a puff of insulin replace a needle for diabetes?
- Could a quick insulin shot stop Steroid-Induced blood sugar spikes?
- Can a puff of insulin replace a daily shot for diabetes?
- Could a Dairy-Rich diet tame type 2 diabetes?
- Can a traditional herbal remedy tame type 2 diabetes?